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Oxidative stress is a hallmark of many liver diseases including viral and drug-induced hepatitis, ische-
mia-reperfusion injury, and non-alcoholic steatohepatitis. One of the consequences of oxidative stress in
the liver is deregulation of Ca2þ homeostasis, resulting in a sustained elevation of the free cytosolic Ca2þ
concentration ([Ca2þ]c) in hepatocytes, which leads to irreversible cellular damage. Recently it has been
shown that liver damage induced by paracetamol and subsequent oxidative stress is, in large part,
mediated by Ca2þ entry through Transient Receptor Potential Melastatin 2 (TRPM2) channels. Involve-
ment of TRPM2 channels in hepatocellular damage induced by oxidative stress makes TRPM2 a potential
therapeutic target for treatment of a range of oxidative stress-related liver diseases. We report here the
identiﬁcation of curcumin ((1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione), a
natural plant-derived polyphenol in turmeric spice, as a novel inhibitor of TRPM2 channel. Presence of
5 mM curcumin in the incubation medium prevented the H2O2- and paracetamol-induced [Ca
2þ]c rise in
rat hepatocytes. Furthermore, in patch clamping experiments incubation of hepatocytes with curcumin
inhibited activation of TRPM2 current by intracellular ADPR with IC50 of approximately 50 nM. These
ﬁndings enhance understanding of the actions of curcumin and suggest that the known hepatoprotective
properties of curcumin are, at least in part, mediated through inhibition of TRPM2 channels.
Crown Copyright & 2015 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The increased production of reactive oxygen and nitrogen
species plays a central role in development of a number of liver
disorders associated with hepatocellular death and impaired cell
regeneration [1–3]. Liver injury induced by drug toxicity, ische-
mia-reperfusion, excessive alcohol consumption and viral hepatitis
is mediated by oxidative stress. Curcumin, ((1E,6E)-1,7-bis-(4-hy-
droxy-3-methoxyphenyl)-1,6-heptadien-3,5-dione), a polyphenol
found in the rhizome of Curcuma longa plant, has for centuries
been used in traditional medicine in many Asian countries for
treatment of liver disorders associated with oxidative stress [4].
Recent research have demonstrated that curcumin has a range of
antioxidant and anti-inﬂammatory properties that can explain its
hepatoprotective effects [5–8]. Previously it has been shown that
curcumin is very effective in preventing liver damage induced by
paracetamol overdose, and that the level of protection afforded by
curcumin against paracetamol-induced liver damage is compar-
able to that of N-acetyl cysteine (NAC), which is presently the main
clinical treatment for paracetamol overdose in humans [9,10]. Itevier B.V. This is an open access ar
chool of Medicine, Universityhas been suggested that the beneﬁcial effects of curcumin in
paracetamol overdose are mainly mediated by its ability to sca-
venge free radicals, to induce expression of antioxidant enzymes
and to inhibit NF-kB, the transcription factor involved in regula-
tion of pro-inﬂammatory pathways [11]. However, our recent re-
search into the role of Transient Receptor Potential Melastatin 2
(TRPM2) channels in oxidative stress-induced liver damage during
paracetamol overdose suggests that some other mechanisms, un-
related to free radical scavenging, may also play an important role
in paracetamol-induced liver toxicity [12].
One of the features of hepatocellular death mediated by oxi-
dative stress is Ca2þ overload due the release of Ca2þ from in-
tracellular organelles and activation of ion channels on the plasma
membrane [12,13]. We have shown that TRPM2 channels activated
by intracellular ADPR are expressed in high numbers in rat and
mouse hepatocytes and are responsible for H2O2- and para-
cetamol-induced persistent Ca2þ rise which causes hepatocellular
damage [12]. Furthermore, experiments using TRPM2 KO mice
have demonstrated that lack of TRPM2 channels signiﬁcantly
protects the liver from paracetamol-induced damage [12]. Con-
tribution of TRPM2 channels to oxidative-stress induced cell da-
mage makes them a potential therapeutic target for treatment of a
range of oxidative stress-related diseases. There are several known
inhibitors of TRPM2 channel, including anthranilic acid (ACA),ticle under the CC BY-NC-ND license
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[12,14–16]. However, none of these agents can be used clinically to
inhibit TRPM2 channels because the concentrations needed to
achieve even partial block are beyond the safety margins. Here,
using Ca2þ imaging and whole-cell patch clamping of primary rat
hepatocytes and HEK293 cells heterologously expressing TRPM2
channels, we show that curcumin inhibits H2O2- and paracetamol-
induced Ca2þ entry and the activation of TRPM2 channels by ADPR
with IC50 of 50 nM. The presented data suggests that curcumin is
the most potent inhibitor of TRPM2 channels discovered so far.2. Methods and materials
2.1. Chemicals
Paracetamol, ADPR, pleuronic acid, curcumin, BSA and NAC
were purchased from Sigma-Aldrich (Rockville, Maryland, US).
DMEM, penicillin/streptomycin, and trypsin-EGTA were purchased
from GIBCO (Grand Island, New York, US). Fura2-AM was pur-
chased from Invitrogen (Carlsbad, California, US). FBS was pur-
chased from Bovogen (Melbourne, Australia). Tris and glycerin
were purchased from Amresco (Solon, Ohio, US).
2.2. Animals
Hooded Wistar rats were housed and bred in the controlled
environment with a 12-h light–dark cycle at least three weeks
before beginning the experiments. Male rats aged 8–12 weeks
were used for the experiments. All experiments were approved by
the Animal Ethics Committees of the University of Adelaide and
Flinders University of South Australia.
2.3. Solutions
Washing media for hepatocyte preparation (mM): 136 NaCl,
4.7 KCl, 0.85 Na2HPO4, 0.45 KH2PO4, 24 NaHCO3, 20 glucose,
1.3 CaCl2, 0.8 MgSO4, BSA (10% W/V), penicillin (100 U/ml), strep-
tomycin (100 mg/ml) and phenol red (0.001% W/V). Krebs–Ringer–
Hepes (KRH) solution (mM): 136 NaCl, 4.7 KCl, 1.3 CaCl2, 1.25
MgCl2, 10 glucose and 10 Na-HEPES with pH adjusted to 7.4 by
NaOH. Control bath solution for patch clamping (mM): 140 NaCl,
4 CsCl, 2 CaCl2, 2 MgCl2 and 10 Na-HEPES, adjusted to pH 7.4 with
NaOH. Pipette solution for patch clamping (mM): 130 caesium
glutamate, 5 MgCl2, 5 CaCl2, 10 EGTA and 10 HEPES, adjusted to pH
7.3 with NaOH. Tris-buffered saline (TBS solution) (mM): 150 NaCl
and 25 Tris with pH adjusted to 7.4 by HCl. TBST solution: TBS
solution plus 0.1% Tween-20. Phosphate buffered saline (PBS) so-
lution (mM): 137 NaCl, 2.7 KCl, 10 Na2HPO4 and 1.8 KH2PO4.
2.4. Hepatocyte isolation and culture
The isolated hepatocytes were prepared using in situ liver
perfusion with collagenase as previously described [17]. The iso-
lated hepatocytes were cultured on glass coverslips at 37 °C in 5%
CO2 in air (v/v) in DMEM containing penicillin (100 U/ml), strep-
tomycin (100 mg/ml) and 10% FBS (v/v) for 16 to 96 hours before
the experiments.
2.5. HEK 293T cell line culture and transfection
HEK 293T cells were cultured in 75 cm2 ﬂasks at 37 °C in 5%
CO2 in air (v/v) in DMEM containing penicillin (100 U/ml), strep-
tomycin (100 mg/ml) and 10% FBS (v/v). Cells were harvested using
PBS containing EGTA. The harvested cells were plated onto glass
coverslips and 8 h later transfected with pCIneo expression vectorcontaining human TRPM2 cDNA (generously provided by Professor
Yasuo Mori, Japan) using TrueFect transfection reagent (United
BioSystems Inc., US). Sixteen hours later, the transfected HEK 293T
cells were used for the patch-clamp experiments.
2.6. Calcium imaging
Fura2-AM was dissolved in 5 ml of 20% pluronic acid in DMSO
(w/v) and diluted in KRH buffer to the ﬁnal concentration of 5 mM.
Sixteen hours after plating on glass coverslips, the hepatocytes
were loaded with Fura2-AM for 30 min, washed and incubated in
KRH solution for 10 min in the CO2 incubator at 37 °C. The ﬂuor-
escence of Fura-2 was recorded using a Nikon TE300 Eclipse mi-
croscope equipped with a Sutter DG-4/OF wavelength switcher,
Omega XF04 ﬁlter set for Fura-2, Photonic Science ISIS-3 ICCD
camera and UIC Metaﬂuor software. Fluorescence images were
obtained every 10 s using a 20objective. Fluorescence ratio va-
lues (340/380 nm) were transformed to [Ca2þ]c using the equation
derived by Grynkiewicz, Poenie & Tsien, 1985 [18]; a Kd of 224 nM
for binding of Fura-2 to Ca2þ; and ionomycin and EGTA to de-
termine Rmax and Rmin, respectively.
2.7. Patch-clamp recording
Membrane currents were measured at room temperature
(23 °C) using standard patch clamping in a whole-cell mode, and a
computer-based EPC-9 patch-clamp ampliﬁer run by PULSE soft-
ware as described previously [12]. In order to monitor the devel-
opment of membrane currents, voltage ramps between 120 and
þ120 mV were applied every two seconds following the
achievement of whole-cell conﬁguration. The holding potential
was 40 mV. The data were analyzed using PULSEFIT software.
The TRPM2 current was activated by adding 0.1 mM or 1 mM
ADPR to the pipette solution. Patch pipettes were pulled from
borosilicate glass and ﬁre-polished to a resistance between 1.5 and
2.5 MΩ. The series resistance did not exceed 7.5 MΩ and was 50%
to 70% compensated.
2.8. Statistical analysis
Data are presented as means 7 standard error of the mean
(SEM). Statistical signiﬁcance was determined using analysis of
variance (ANOVA), followed by the Bonferroni post hoc test and
Student’s t-test (two tailed).3. Results
Previously, we have shown that inhibition of TRPM2 channels
diminishes paracetamol- and H2O2-induced hepatocellular death
in culture and that TRPM2 KO mice are signiﬁcantly less suscep-
tible to paracetamol-induced liver damage, compared to WT mice
[12]. At the same, it has been demonstrated in rat and mouse that
paracetamol toxicity can be ameliorated by intraperitoneal injec-
tion of curcumin prior to administration of paracetamol [8,18]. To
investigate whether liver-protective properties of curcumin are
related, in any way, to TRPM2, ﬁrst, we used Ca2þ imaging to as-
certain the effects of curcumin on paracetamol-induced [Ca2þ]c
rise. Isolated rat hepatocytes plated on glass cover slips were in-
cubated for 60 min with or without paracetamol (10 mM) in the
presence or absence of 5 mM curcumin in KRH bath solution con-
taining 1.3 mM Ca2þ . Treated hepatocytes were then loaded with
Fura-2AM in a nominally Ca2þ free KRH and, after washing, were
transferred to the microscope stage. Introduction of 1.3 mM Ca2þ
to the bath resulted in [Ca2þ]c increase to levels above 3 mM in the
paracetamol-treated hepatocytes incubated in the absence of
Fig. 1. Curcumin inhibits paracetamol- and H2O2-induced [Ca2þ]c rise in rat hepatocytes. (A) Ca2þ entry activated in hepatocytes treated with paracetamol, 10 mM for
60 min, in the presence or absence of 5 mM curcumin. Control – untreated hepatocytes (B) Peak [Ca2þ]c in the control, curcumin-, paracetamol-, and paracetamol- and
curcumin-treated hepatocytes 15 min after introducing 1.3 mM Ca2þ to the bath. (C) Ca2þ entry activated in hepatocytes treated with 0.5 mM H2O2 in the presence or
absence of 5 mM curcumin. (D) Peak [Ca2þ]c in the control, curcumin-, H2O2-, and H2O2- and curcumin-treated hepatocytes 15 min after introducing 1.3 mM Ca2þ to the
bath. [Ca2þ]c was calculated using equation derived by Grynkiewicz, Poenie and Tsien (1985) [17].
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for cells incubated in the absence of paracetamol. These results
indicate that, as shown previously [12], treatment with para-
cetamol activates Ca2þ entry across the plasma membrane
through Ca2þ permeable channels (Fig. 1A and B). In contrast,
hepatocytes treated with paracetamol in the presence of curcumin
showed no change in [Ca2þ]c (Fig. 1A and B).
Rat hepatocytes incubated in the presence of 0.5 mM H2O2 for
30 min, showed a large rise in [Ca2þ]c after the introduction of
1.3 mM Ca2þ to the bath (Fig. 1C and D) [12]. Previous results
obtained using TRPM2 KO mice and inhibitors of TRPM2 and patch
clamp recording have provided evidence that H2O2-initiated in-
crease in [Ca2þ]c was almost entirely due to Ca2þ entry through
TRPM2 channels [12]. This H2O2-induced increase in [Ca2þ]c was
inhibited by the inclusion of curcumin in the 30 min incubation
period. Taken together, the Fura2 Ca2þ imaging results indicate
that, at a concentration of 5 mM, curcumin completely inhibits the
paracetamol- and H2O2-induced increases in [Ca2þ]c. in
hepatocytes.
Whole-cell patch-clamp recordings conﬁrmed the ﬁndings of
Ca2þ imaging experiments (Fig. 2). As we showed previously,
isolated rat hepatocytes treated with paracetamol for 60 min and
then used for whole-cell patch clamping, exhibited a large non-
selective cation current, mediated mostly by TRPM2 channels [12].Addition of 5 mM curcumin into incubation medium together with
paracetamol prevented development of any current above back-
ground conductance seen in untreated hepatocytes (Fig. 2A and B).
Similarly, incubation with H2O2 (0.5 mM for 30 min) prior to
achieving whole cell conﬁguration resulted in a large non-selec-
tive cation current, which was absent if curcuminwas added to the
medium together with H2O2 (Fig. 2C and D).
In the experiments described above curcumin was present in
the medium during the treatments (H2O2 or paracetamol) that
cause oxidative stress-induced cell damage. In both cases, curcu-
min could work as a ROS scavenger, reducing oxidative stress, and
therefore, preventing the generation of ADPR and subsequent ac-
tivation of TRPM2 channels. It is possible, however, that curcumin
interacts with TRPM2 directly, as it does with some other chan-
nels, including TRPA1 and TRPV1 [19–21]. To investigate such a
possibility, TRPM2 current was activated by intracellular applica-
tion of 1 mM ADPR through a patch pipette using hepatocytes
incubated with curcumin, 5 mM in the bath for 15–20 min. Whole-
cell patch clamping showed that activation of TRPM2 current by
ADPR was almost completely inhibited by curcumin (Fig. 3). It
should be noted here that curcumin had an inhibitory effect on
TRPM2 only if applied to the bath prior to achieving whole-cell
conﬁguration. If applied to the bath after the development of the
current, curcumin had no effect on TRPM2, even at 50 mM
Fig. 2. Curcumin inhibits activation of a non-selective cation current in hepatocytes treated with paracetamol or H2O2. (A) Averaged current–voltage plots recorded in
response to 100 ms voltage ramps between 120 and 120 mV in untreated hepatocytes (control, n¼5), hepatocytes treated with 10 mM paracetamol for 60 min in control
bath solution (paracetamol, n¼5), and hepatocytes treated with 10 mM paracetamol and 5 mM curcumin for 60 min (paracetamolþcurcumin, n¼6). (B) The average am-
plitude of TRPM2-mediated Naþ current, obtained by replacing Naþ in the bath solution with NMDGþ , in untreated hepatocytes (control) and hepatocytes treated with
10 mM paracetamol in the presence or absence of 5 mM curcumin for 60 min. (C) Averaged current–voltage plots recorded in response to 100 ms voltage ramps between
120 and 120 mV in untreated hepatocytes (control, n¼5), hepatocytes treated with 0.5 mM H2O2 for 30 min (H2O2, n¼5), and hepatocytes treated with 0.5 mM H2O2 in
the presence of 5 mM curcumin for 30 min (H2O2þcurcumin, n¼5). (D) The average amplitude of TRPM2-mediated Naþ current, obtained by replacing NaCl in the bath
solution with NMDGCl, in untreated hepatocytes (control) and hepatocytes treated with 0.5 mM H2O2 for 30 min, in the presence or absence of 5 mM curcumin. Standard
errors in panels A and C are omitted for clarity.
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cysteine (NAC), which is used in therapy for paracetamol overdose,
has any effect on TRPM2. In contrast to curcumin, NAC applied to
the bath at 100 mM for up to 60 min before the patch clamping had
no effect on activation of TRPM2 currents by ADPR (Fig. 3).
Lack of any blocking effect of curcumin on TRPM2 current after
full current development suggests that curcumin does not block
the TRPM2 pore, but affects the mechanism of channel activation
by ADPR. One of the possibilities is that curcumin interferes with
ADPR binding to the Nudix motif in the TRPM2 C-terminus. To gain
some insight into this we used HEK293T cells transfected with
hTRPM2 cDNA and whole cell patch clamping. Similarly to TRPM2
current in hepatocytes, current mediated by TRPM2 hetero-
logously expressed in HEK293T cells was completely inhibited by
5 mM curcumin applied to the bath 15 min prior to patch clamping
(Fig. 4A and B). To investigate whether curcumin competes with
ADPR for the binding site on TRPM2, we obtained dose-response
curves for curcumin at two ADPR concentrations (0.1 and 1 mM)
(Fig. 4C). The IC50 values derived from the dose-response curves
were not signiﬁcantly different, 42717 nM and 53716 nM for
0.1 mM and 1 mM ADPR, respectively. This suggests that there is
no competition between ADPR and curcumin.To determine the reversibility of inhibition of TRPM2 by cur-
cumin, we conducted patch clamping experiments using HEK293T
cells transfected with TRPM2 cDNA and attempted to remove
curcumin from the bath by washing. However, we were unable to
observe any change in the degree of inhibition before the patch
was lost. Therefore, to determine the reversibility of inhibition of
TRPM2 by curcumin, the transfected HEK293T cells were in-
cubated with 2 mM curcumin for 15 min, then washed with normal
bath media for 10 min and used for patch clamping with 1mM
ADPR in the pipette solution. The amplitude of TRPM2 current in
cells treated with and then washed of curcumin was 101723 pA/
pF, compared to 4917133 pA/pF in untreated cells, suggesting
that curcumin had a long-lasting effect on TRPM2 activation
(Fig. 4D).4. Discussion
The results reported in this work indicate that curcumin in-
hibits development of TRPM2 current in response to oxidative
damage or intracellular application of ADPR, but does not block
active TRPM2 channels. Our previous studies have provided
Fig. 3. Curcumin, but not N-Acetylcysteine inhibits activation of TRPM2 current in hepatocytes by ADPR. (A) Development of TRPM2 current in response to 0.1 mM in-
tracellular ADPR in untreated hepatocytes (control), hepatocytes treated with 5 mM curcumin for 15 min (curcumin), and hepatocytes treated with 100 mM NAC for 15 min
(NAC). Current was recorded in response to 100 ms voltage ramps between 120 and 120 mV, applied every two seconds. Average current amplitude at 100 mV is plotted
against time (n¼6 for each condition). Standard errors are omitted for clarity. (B) The amplitude of the ADPR-activated TRPM2 current under conditions indicated on the X-
axis, determined by replacing NaCl with NMDGCl in bath solution. The amplitude of Naþ current recorded in hepatocytes with no ADPR added to the pipette solution is
shown for comparison (no ADPR).
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hepatocytes by H2O2 or paracetamol involves the formation of
ADPR in response to oxidative stress-induced DNA damage [12].
Binding of ADPR to Nudix-like domain in the C-terminus of TRPM2
leads to opening of TRPM2 channel pore and Naþ and Ca2þ entry
(for review see [22]). In this study, we show for the ﬁrst time that
curcumin is an inhibitor of one or more steps in the pathway by
which TRPM2 is activated by ADPR.
Curcumin, a component of turmeric spice, has been used in
India and other countries in South-East Asia for medicinal pur-
poses for centuries [23]. In recent years, it has been shown that
curcumin is a free-radical scavenger and a powerful antioxidant,
which possess anti-inﬂammatory, anti-carcinogenic, neuro-pro-
tective, liver-protective and many other properties, which make
curcumin a potential therapeutic agent for treatment of a number
of human diseases [6,24–29]. Measurements of free radical
scavenging properties of curcumin and its analogues using cell-
free assays (TEAC, FRAP, and ORAC) showed that ferulic acid, a
curcumin monomer, is a more powerful free radical scavenger
than curcumin itself. However, in cell culture studies, the bene-
ﬁcial antioxidant effects of curcumin are signiﬁcantly stronger
than those of ferulic acid [4]. This suggests that the medicinal
properties of curcumin are mostly mediated through its interac-
tions with the transcription factors and enzymes in the en-
dogenous anti-oxidant and anti-inﬂammatory pathways, rather
than just through free-radical scavenging mechanism [30].
Experiments using a number of animal models indicate that
curcumin attenuates liver damage caused by ethanol, thioaceta-
mide, CCl4, iron overdose, cholestasis, and paracetamol overdose
[6,8,9,31]. Curcumin can even reverse, to some extent, liver cir-
rhosis caused by chronic administration of CCl4 [31]. The exact
molecular mechanisms of liver protective properties of curcumin
remain to be established, however, its antioxidant activity and
inhibition of NF-κB transcription factors and dependent pro-in-
ﬂammatory pathways are likely to play a major role [7,30]. The
data presented in this study add inhibition of TRPM2 channels to
the list of possible mechanisms of liver protection by curcumin.
Our recent investigation of the mechanisms of paracetamol liver
toxicity indicate that oxidative stress-induced activation of TRPM2
channels that mediate Ca2þ overload and loss of intracellular Kþconstitutes a major pathway contributing to hepatocellular death
[12]. In paracetamol overdose in vivo, curcumin may work as an
antioxidant and free-radical scavenger, reducing damage to mi-
tochondria and DNA, thus inhibiting production of ADPR, the main
agonist of TRPM2. Such a mechanism is proposed for the protec-
tive effect of NAC, a sulfhydryl donor, which contributes to re-
generation of GSH, against oxidative stress-induced cellular da-
mage [32]. Pre-incubation of DRG neurons with NAC has been
shown to inhibit activation of TRPM2 current by H2O2, most likely
due to increased levels of GSH in the cells [32]. The patch clamping
data presented in this study, however, indicate that NAC has no
effect on activation of TRPM2 by ADPR. This suggests that a pos-
sible increase in GSH levels in hepatocytes in response to curcu-
min plays no role in the mechanism of inhibition of TRPM2 acti-
vation by ADPR. The mechanism of TRPM2 inhibition by curcumin
is not yet clear; however, it does not involve a direct block of the
pore, or competition of curcumin with ADPR for the binding site. A
very slow wash-out of curcumin could be the evidence of strong
binding, with slow off rate, of curcumin to TRPM2, or evidence of
partitioning of curcumin into lipid membrane where it can interact
with hydrophobic regions of TRPM2 protein. Alternatively, curcu-
min may cause TRPM2 modiﬁcation through yet unknown path-
way, which affects its function or localization.
Previously curcumin has been shown to inhibit a number of ion
channels, including Kv1.3, Kv1.4, Kv11.1, TREK-1, and Ca2þ release
activated Ca2þ (CRAC) channel [33–35]. However, the IC50 of cur-
cumin for all these channels was 10–100 times higher than the
IC50 of curcumin for TRPM2 found in this study (50 nM). The
mechanisms of inhibition of different types of channels by cur-
cumin are also likely to be different, ranging from fast and easily
reversible block of Kv1.4 channels [33] to slow and virtually irre-
versible block of TRPM2 activation found in this study.5. Conclusions
In conclusion, the IC50 for curcumin (50 nM) and even the
concentration required for a complete block of TRPM2 (1 mM)
are well within the safety margins for its human consumption
[27,36,37]. This makes curcumin a potential therapy for diseases
Fig. 4. Curcumin inhibits ADPR-mediated activation of TRPM2 channels heterologously expressed in HEK 293T cells. (A) Activation of TRPM2 current by 1 mM intracellular
ADPR in TRPM2-transfected HEK 293T cells in normal bath solution (control), and after treatment with 5 mM curcumin for 15 min (curcumin). Current was recorded in
response to 100 ms voltage ramps between 120 and 120 mV, applied every two seconds. Average current amplitude at 100 mV is plotted against time (n¼6 for each
condition). (B) Current–voltage plots of ADPR-activated current in TRPM2-transfected HEK 293T cells in normal bath solution (control) and cells treated with 5 mM curcumin
for 15 min (curcumin). (C) The dose-response relations of curcumin inhibition of TRPM2 current in transfected HEK 293T cells at two different concentrations of ADPR in the
patch pipette (0.1 and 1 mM). The amplitude of ADPR-activated current at 100 mV is plotted against curcumin concentrations (n¼5 for each condition). The experimental
data points are ﬁtted with Hill equation with variable slope. The IC50 of curcumin block of ADPR-activated current were 42717 nM and 53716 nM for 0.1 and 1 mM ADPR,
respectively. The Hill slope was 2.3 and 3.3 for 0.1 and 1 mM ADPR, respectively. (D) The wash-out the effect of curcumin on ADPR-activated current in TRPM2-expressing
HEK 293T cells. The average amplitude of TRPM2 current measured at 100 mV in cells incubated in the normal bath solution (control), incubated with 2 mM curcumin for
15 min (curcumin), and incubated with 2 mM curcumin for 15-min and then washed out for 10 min (curcumin wash-out).
E. Kheradpezhouh et al. / Redox Biology 7 (2016) 1–76where deleterious effects of oxidative stress, at least in part, are
due to aberrant Ca2þ entry mediated by TRPM2 channels. Curcu-
min has already been suggested as a treatment for some neuro-
degenerative conditions, and TRPM2 channels are expressed in
very high numbers in the brain and have been implicated in
neurodegeneration [24,26,28]. It is possible that inhibition of
TRPM2 channels, in addition to free radical scavenging, is the
mechanism by which curcumin protects cells from oxidative
stress-induced damage.Acknowledgments
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